We’re on track to develop the first-ever FDA-approved drug for longevity – for any species,” Celine Halioua told The Post.

In February 2024, when Boo the Whippet became the first patient in a clinical trial of a life-extending drug for senior dogs, a call was put out for more canines. A milestone was reached in the ...

SAN FRANCISCO--(BUSINESS WIRE)--Loyal, a biotech company pioneering longevity drugs for dogs, announced today that it has dosed the first dog in its STAY study, the pivotal clinical trial for its ...

In fact, Tarantino has started the enrollment process for her own dog, an 11-year-old husky mix named Jose, in STAY, Loyal’s latest pivotal effectiveness trial for LOY-002’s Food and Drug ...

Boo the dog, the first patient of Loyal's STAY trial testing out their LOY-002 drug ... the Food and Drug Administration told Loyal it had a “reasonable expectation of effectiveness ...